FDA expands approval of breast cancer drug Kisqali to earlier stage patients
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
Get the Full StoryThe FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said.